Bergés GarcíaA, Vélez MA, Ríos OMG, Rodríguez C, García CJ, López AJL, Kreuz W, Tezanos PM

Language: Spanish
References: 6
Page: 84-88
PDF size: 85.45 Kb.

ABSTRACT

National and international experts gathered in order to analyze the current treatment for haemophilia in Mexico and to compare it with its management in other countries. The aims are collecting proposals which will lead to homogenize the clinical guidelines and recording demonstrating cases. These ones will provide basic epidemiological information to take decisions and distribute the resources according to a comprehensive programme of control of cases, coordinated by several attention and analysis centres. This document presents the first results about the review of the current management in Mexico and abroad.

REFERENCES

1. Rodriguez NI, Hoots W.K. Advances in Hemophilia: Experimental Aspects and Therapy. Pediatr Clin of North Am 2008; 55(2):357-76.

2. Lin Y, Yang X, Chevrier MC, Craven S, Barrowcliffe TW, Lemieux R, Ofosu FA. Relationships between factor VIII:Ag and factor VIII in recombinant and plasma-derived factor VIII concentrates. Haemophilia. 2004;10(5):459-69.

3. Kisker CT, Eisberg A, Schwartz B; Mononine Study Group. Prophylaxis in factor IX deficiency product and patient variation. Haemophilia 2003;9(3):279-84.

4. GTH-PUP-Study Group. Inhibitor incidence in previously untreated patients (PUPs) with Hemophilia A And B. A Prospective Multi-Center Study of te Pediatric Committee of the German, Swiss and Austrian Society for Thrombosis and Hemostasis Research (GTH). Update June 2004.

5. Schimpf K, Mannucci PM, Kreuz W, Brackmann HH, Auerswald G, Ciavarella N, Mösseler J, DeRosa V, Kraus B, Brueckmann C, et al. Absence of hepatitis after treatment with a pasteurized factor VIII concentrate in patients with hemophilia and no previous transfusions. N Engl J Med 1987;316:918-22.

6. GTH-PUP-Study Group Update February 2012 (Unpublished Data).